Furosemide vs Placebo in Severe Preeclampsia Postpartum

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 186 participants.

Also called NCT07648251

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 186 participants (planned count) (from the registry)
Sponsor
Universidad Nacional Autonoma de Honduras (from the registry)
Registry
  • NCT NCT07648251
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Honduras (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07648251. Randomized; triple masking; primary purpose treatment. Start 2026-11-02 (anticipated); primary completion 2027-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Furosemide vs Placebo in Severe Preeclampsia Postpartum
Acronym
FUROPE
Condition
Severe Preeclampsia
Intervention (Drug)
Furosemide
Intervention (Drug)
Folic Acid 5 MG
Lead sponsor
Universidad Nacional Autonoma de Honduras (class: other)

Record details

Record id
cardio:ct-nct07648251
Content hash
ea80634c2c3afb2cfe6f1414c62aa6825b5a4e57372d01a0d4632ccf22f6d4a3